Glycemic Regulation as Endometriosis Adjunct Treatment

NCT06611501 · ctgov active_not_recruiting phase phase-2
Enrollment
14
Start
2025-05-22
Completion
2027-01-01
Last updated
2026-07-16
Has results
False
Countries
United States

Conditions

Pelvic PainEndometriosis

Tagged with

endometriosis

Interventions

Eligibility criteria
Inclusion Criteria: * Female with surgically confirmed endometriosis, determined at laparoscopy * Current use for at least 2 months duration of a consistent hormonal therapy for endometriosis (either combination hormonal contraceptives or progestin-only therapy) * Current pelvic pain (score ≥ 3 on Visual Analog Scale) that has been present for at least 2 months prior to enrollment * Age 15 years to 35 years and premenopausal * Willingness to comply with visit schedule and protocol Exclusion Criteria: * Pre-menarche or post-menopause * Diagnosis of Type 1 or Type 2 Diabetes Mellitus * Severe renal dysfunction (creatinine \>1.4 mg/dL or eGFR below 45 mL/minute/1.73 m2 * History of lactic acidosis or diabetic ketoacidosis * ALT or AST \> 2.5 times the upper limit of normal * Significant mental or chronic systemic illness that might confound pain assessment or the inability to complete the study * Current/planning pregnancy or breastfeeding * Inability to read English
License: public-domain-us · commercial use OK · attribution required
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine

No linked papers in the corpus yet.